NDC 49288-0022
White Ash
White Ash
White Ash is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Fraxinus Americana Pollen.
| Product ID | 49288-0022_13c9eea1-38b5-472b-b735-a814ca886718 |
| NDC | 49288-0022 |
| Product Type | Human Prescription Drug |
| Proprietary Name | White Ash |
| Generic Name | White Ash |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | FRAXINUS AMERICANA POLLEN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0022-5
50 mL in 1 VIAL, MULTI-DOSE (49288-0022-5)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0022-2 [49288002202]
White Ash INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0022-4 [49288002204]
White Ash INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0022-5 [49288002205]
White Ash INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0022-3 [49288002203]
White Ash INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0022-1 [49288002201]
White Ash INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| FRAXINUS AMERICANA POLLEN | .05 g/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "White Ash" or generic name "White Ash"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2493 | White Ash | White Ash |
| 36987-2494 | White Ash | White Ash |
| 36987-2495 | White Ash | White Ash |
| 36987-2496 | White Ash | White Ash |
| 36987-2497 | White Ash | White Ash |
| 36987-2498 | White Ash | White Ash |
| 36987-2499 | White Ash | White Ash |
| 36987-2500 | White Ash | White Ash |
| 49288-0021 | White Ash | White Ash |
| 49288-0022 | White Ash | White Ash |
| 0268-6603 | FRAXINUS AMERICANA POLLEN | White Ash |
| 0268-6680 | FRAXINUS AMERICANA POLLEN | White Ash |
Trademark Results [White Ash]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 WHITE ASH 90647029 not registered Live/Pending |
Green Growth Technologies, LLC 2021-04-15 |
 WHITE ASH 90356549 not registered Live/Pending |
PHamily Affair, LLC 2020-12-03 |
 WHITE ASH 88313414 not registered Live/Pending |
BSI LLC 2019-02-24 |
 WHITE ASH 80986789 0986789 Dead/Cancelled |
Parodi Cigar Corporation 0000-00-00 |
 WHITE ASH 75637289 2391017 Dead/Cancelled |
Cold Spring Granite Company 1999-02-09 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.